2B9-Fc Ameliorates Immune Thrombocytopenia by Suppressing STAT1-Mediated M1 Macrophage Polarization and Expanding Regulatory T Cells
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder in which enhanced platelet destruction and impaired platelet production coexist, and a substantial proportion of patients remain refractory to available therapies. Here, we evaluated 2B9-Fc, a thrombopoietin (TPO) mimetic peptide engineered from a cyclic...